Stock-index futures Thursday evening surged, implying that equity gauges may be set to add considerably to modest gains put in during the regular session that closed at 4 p.m. Eastern Time. Gains were being partly attributed to a report from health-care media site Stat that indicated promising results from therapeutics used to treat the novel strain of coronavirus . The report indicated that 125 COVID-19 patients in a study were discharged after treatment with Gilead's remdesivir. However, the results represent a very small sample and don't qualify as clinical data. Still investors appeared heartened by the report as the deadly pathogen has claimed 140,000 lives and infected more than 2 million people globally, shutting down large swaths of economies world-wide. Meanwhile, Boeing Co. BA,
, which tumbled 8% in regular trade, saw its shares pop after the aeronautics manufacturer said it would resume making planes . The company has been under pressure due to the coronavirus outbreak and the grounding of its 737 MAX fleet. Futures for the Dow Jones Industrial Average YMM20 were up 774 points, or 3.3%, at 24,182, at last check. S&P 500 index futures SPX,
